eng
Iranian Society of Dermatology
Iranian Journal of Dermatology
2717-0721
2013-10-01
16
4
121
127
98201
Original Article
Threat appraisal for skin cancer among rural farmers in Ilam, Iran
Tazval Jafar
1
Ghaffari Mohtasham
2
Robati Reza M
3
Background: Skin cancers are among the most prevalent malignancies in Iran. According to statistics, it is the most common cancer in the population of Ilam, west of Iran. The present study aimed to assess threat appraisal of skin cancer among rural farmers of Ilam in 2013-2014.Method: In this cross-sectional study, we used multistage random sampling. We collected the data through distribution of a researcher-developed questionnaire among 248 farmers from the rural areas of Ilam in June 2013. The items of the questionnaire were based on the protection motivation theory, and covered components included perceived vulnerability, perceived severity, and rewards. Result: We found a generally lower perceived vulnerability and severity and higher rewards among the farmers; 14.5 and 30.6 % of the farmers displayed higher perceived vulne
https://www.iranjd.ir/article_98201_b0758fca24c9061b8c963dc6adcab464.pdf
farmers
Protection motivation theory
Skin Cancer
threat appraisal
eng
Iranian Society of Dermatology
Iranian Journal of Dermatology
2717-0721
2013-10-01
16
4
128
131
98200
Original Article
Impact of dermatological diseases on family members of the patients using Family Dermatology Life Quality Index: A preliminary study in Iran
Handjani Farhad
1
Kalafi Amir
2
Background: Chronic skin diseases such as vitiligo and psoriasis can impair the quality of life in the patients with these diseases. The impact of chronic and/or severe skin diseases on the lives of family members of the affected patients has only recently been addressed. The tool used for this assessment is the Family Dermatology Life Quality Index (FDLQI). The aim of this study was to use the FDLQI to assess the impact of four skin diseases (pemphigus, psoriasis, vitiligo, and cutaneous leishmaniasis) on family members of the affected patients.Method: Fifty healthy family members of 50 patients with pemphigus, psoriasis, vitiligo, and cutaneous leishmaniasis were included in this study. The patients had to have an extensive disease with disease duration of at least one month. One family member of each patient completed the 10- item Persian version of the FLDQI questionnaire. The score of this index ranged from 0 to 30.Result: The mean duration and mean FDLQI score of the diseases were as follows: psoriasis (mean duration=4.1±2.7, mean FDLQI score=14.7±5.01), pemphigus (mean duration=3.6±2.3, mean FDLQI score=15.4±4.7), vitiligo (mean duration=5.1±4.05, mean FDLQI score=14.4±5.08) and cutaneous leishmaniasis (mean duration=0.62±0.23, mean FDLQI score=12.0±4.3). There was no significant difference among the groups (p=0.562). In addition, no strong correlation was observed between the mean duration of the disease and mean FDLQI scores for each condition (r=0.051, p=0.726).Conclusion: This small-scale study demonstrated that although not statistically significant, inflammatory diseases like pemphigus had a higher FDLQI score when compared to non-inflammatory conditions like vitiligo and short-term conditions such as leishmaniasis.
https://www.iranjd.ir/article_98200_ee0fcbbf56ea3e40388c17b7751a5bda.pdf
Cutaneous leishmaniasis
family dermatology life quality index
Quality of Life
pemphigus
Psoriasis
skin disease
Vitiligo
eng
Iranian Society of Dermatology
Iranian Journal of Dermatology
2717-0721
2013-10-01
16
4
132
136
98202
Original Article
Eficacy of calcipotriol in the treatment of seborrheic keratosis: a pilot study
Yousefi Maryam
1
Nabaei Leyla
2
Ghasemnia Hassan
3
Abolhasani Ehsan
4
Rahgoshai Rayhaneh
5
Barikbin Behrooz
6
Background: Seborrheic keratosis is a common benign tumor and many modalities are used to treat it. No convincing data favors the therapeutic effect of calcipotriol on seborrheic keratosis. We aimed to assess the efficacy of calcipotriol in the treatment of this tumor.Method: Eligible patients aged over 40 years with seborrheic keratosis (size: 5-15mm) were instructed to apply 50?g/g calcipotriol ointment twice a day for 12 weeks. The size of the tumor was measured at baseline and after the 12-week period. The size change and improvement were assessed. Result: Thirty out of fifty screened patients were eligible for the study and completed the 12-week course of the study. The mean baseline size of the tumors was 9.30±2.95 mm that decreased to the mean size of 2.02±1.94 mm (P
https://www.iranjd.ir/article_98202_6c51f716f09aac3f658ef9dc1a517477.pdf
calcipotriol
seborrheic keratosis
topical administration
vitamin D analogues
eng
Iranian Society of Dermatology
Iranian Journal of Dermatology
2717-0721
2013-10-01
16
4
137
140
98203
Original Article
Creatine phosphokinase values and myalgia during isotretinoin therapy
Ghiasi Maryam
1
Lajevardi Vahide
2
Mortazavi Hossein
3
Damavandi Maedeh Raiyati
4
Background: Systemic isotretinoin is a very effective medication for the treatment of acne, but it has some side effects. One of its side effects is musculoskeletal problems such as increased levels of creatine phosphokinase (CPK), myalgia, and serious muscle damage such as rhabdomyolysis. The aim of this study was to evaluate the incidence of myalgia and its relationship with the elevation of serum CPK levels in patients treated with isotretinoin.Method: This study was done on forty acne patients in Razi Hospital. Isotretinoin was administered at a dose of 0.25 mg/kg in all patients. Serum CPK levels were measured before the treatment and every 2 months during treatment. On each visit, the patients were asked about muscular symptoms such as myalgia.Result: Twenty-eight (70%) patients were female. The mean age of the patients was 22.6±5.4 years. The mean serum CPK level did not increase during treatment with isotretinoin. However, 2.5%, 36.8% and 31.5% of the patients had myalgia 2, 4, and 6 months after the initiation of isotretinoin, respectively. There was no significant difference in the mean CPK level of those who had myalgia after treatment with isotretinoin and those who were asymptomatic.Conclusion: It seems that low dose isotretinoin does not induce the elevation of CPK, but can cause myalgia in some patients irrespective of the CPK level. Myalgia in patients under treatment with low dose isotretinoin is a benign phenomenon and is not an alarm for serious muscle damage. Therefore, routine measurement of the CPK level in patients receiving low dose isotretinoin is not recommended.
https://www.iranjd.ir/article_98203_cbe061cda9333ff12f772a95086c36c9.pdf
Acne
creatine phosphokinase
Isotretinoin
myalgia
eng
Iranian Society of Dermatology
Iranian Journal of Dermatology
2717-0721
2013-10-01
16
4
141
143
98204
Original Article
Exfoliative dermatitis: a study from the Northeast of Iran
Yazdanpanah Mohammad Javad
1
Nourbakhsh Reza
2
Fakhrozaman Pezeshkpoor
3
Mahnaz Banihashemi
4
Jamshid Baradaran-Moghadam
5
Background: Exfoliative dermatitis is a rare disorder with several etiologic factors. The frequency of different etiologies varies in the medical literatures. The purpose of this study was to reveal the demographic characteristic and etiologies of exfoliative dermatitis in our department.Method: We reviewed the records of the patients who were admitted to the dermatology ward of Ghaem Hospital, Mashhad, Iran, with a diagnosis of exfoliative dermatitis in a twenty-year period (1982-2002). Age, gender, the cause of exfoliative dermatitis, and the most probable drug cause were studied. Result: Fifty-nine cases were included in the study. Male-female ratio was 1.27:1. The mean age of the patients was 50.11±19.37. The most common causes were psoriasis (40.7%), drugs (18.6%) and lymphoma (18.6%). The most common drugs that caused exfoliative dermatitis were co-trimoxazole (27.27%), carbamazepine (18.18%), and gold salts (18.18%). Conclusion: The most frequent of underlying cause of exfoliative dermatitis in our series was psoriasis. Co-trimoxazole was the most common drug that caused exfoliative dermatitis.
https://www.iranjd.ir/article_98204_f1cff2408965086ea78070d85a3bb88d.pdf
erythroderma
etiology
exfoliative dermatitis
eng
Iranian Society of Dermatology
Iranian Journal of Dermatology
2717-0721
2013-10-01
16
4
144
158
98205
A review of three systemic retinoids in dermatology: acitretin, isotretinoin and bexarotene
Mortazavi Hossein
1
Aghazadeh Nessa
2
Ghiasi Maryam
3
Lajevardi Vahideh
4
Retinoids are synthetic and natural analogues of vitamin A that have various effects on cellular differentiation, cellular proliferation, immune system, and embryonic development. The present study reviews the history of systemic retinoids in medicine, the structure of syn
https://www.iranjd.ir/article_98205_1fdaa34c45ff92c322b6c2dcc95a4826.pdf
acitretin
bexarotene
etretinate
Isotretinoin
retinoids
eng
Iranian Society of Dermatology
Iranian Journal of Dermatology
2717-0721
2013-10-01
16
4
159
161
99685
Repigmentation of vitiliginous facial area after Q-switched Nd-YAG laser therapy for depigmentation: Is it a case of true reverse Koebner phenomenon in vitiligo?
Mohammad Radmanesh
radmanesh_m@yahoo.com
1
Nasibeh Sohrabian
2
Ramin Radmanesh
3
The patients with universal vitiligo and residual pigmented patches usually do not benefit from available repigmenting methods and are better scheduled for depigmentation by medical, laser,and or freezing procedures. A 37-year-old lady with universal vitiligo and remaining pigmentation in the left anterior chest wall, both ventral forearms, and diffuse mottled depigmentation of the face was scheduled for facial depigmentation by 532 nm Q-switched Nd-YAG laser. All residual pigmented facial areas were treated uniformly. Two months after laser therapy, we paradoxically observed considerable repigmentation of the treated areas with only some remaining scattered and round depigmented patches. Through an unknown mechanism, a true reverse Koebner phenomenon with its resultant repigmentation rather than depigmentation was observed in our patient.
https://www.iranjd.ir/article_99685_59499e36421efd063d272fd30944ecd2.pdf
depigmentation
Q-switched Nd-YAG laser
repigmentation
reverse koebner phenomenon
Vitiligo
eng
Iranian Society of Dermatology
Iranian Journal of Dermatology
2717-0721
2013-10-01
16
4
162
164
98206
Acquired universal melanosis (Carbon baby syndrome) in a 4-year old girl
Toossi Parviz
1
Ershadi Sarah
2
Abolhasani Ehsan
3
Universal acquired melanosis is a rare cause of diffuse hyperpigmentation of skin and mucosa during childhood. There are only few reported case of this scarce syndrome in medical literature. We report the first case of universal acquires melanosis from Iran in a 4-year-old girl whose skin becomes darker after 2-month of age.
https://www.iranjd.ir/article_98206_1b84a3bef236cb756101018b04195a67.pdf
Carbon baby
hyperpigmentation
universal acquired melanosis
eng
Iranian Society of Dermatology
Iranian Journal of Dermatology
2717-0721
2013-10-01
16
4
165
167
98207
Bilateral indurated violaceous non-tender plaques on the nasal ala
Qeisari Mehdi
1
Zerehpoosh Farahnaz Bidari
2
Abdollahimajd Fahmimeh
3
Salajeghe Sara
4
A 77-year-old Iranian man was visited at the Dermatology Department of Loghman-e Hakim Hospital affiliated with Shahid Beheshti University of Medical Sciences on June 2012 with bilateral, symmetric, raised, violaceous and painless plaques on the nose (both ala nasi), from one year ago. The lesions were small at first and then grew gradually larger in size. Systemic symptoms such as fever, weight loss and night sweat were absent. He had no history of systemic disease, bite, trauma, vaccination, or medication. Past medical history was negative except for cataract in several years ago and he was in good health. He had a history of treatment with oral antibiotics without any improvement. Physical examination revealed bilateral, symmetric, indurated, violaceous, non-tender plaques on the nose (both ala nasi) with some scales and follicular accentuation without discharge (Figure 1). Other examinations were normal and laboratory tests revealed no abnormality. A skin biopsy was performed.
https://www.iranjd.ir/article_98207_80f2bcb4c992a803651588c94b298794.pdf